{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:35:14Z","timestamp":1772253314082,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,4,25]],"date-time":"2003-04-25T00:00:00Z","timestamp":1051228800000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[2003,4]]},"abstract":"<jats:p><jats:bold>Objective.<\/jats:bold> Our aim was to study the effects of the gonadotropin releasing hormone agonist on the uterine leiomyoma of infertile women.<\/jats:p><jats:p><jats:bold>Material and methods.<\/jats:bold> Sixty\u2010seven nulliparous women (aged 24\u201339\u2003years) with uterine leiomyomas, underwent ultrasonographic study of leiomioma volume, and were divided in two groups. Thirty\u2010one had nodes greater than 300\u2003cm<jats:sup>3<\/jats:sup> and were treated with goserelin 3.6\u2003mg every 28\u2003days for 6\u2003months (group I); the other 36 patients did not receive medication (group II or control group). Sixteen patients from group I had \u2264\u200a36% (median) reduction of the leiomyoma volume (subgroup Ia) and the other 15 women had reduction &gt;\u200a36% (subgroup Ib). All women underwent myomectomy.<\/jats:p><jats:p><jats:bold>Results.<\/jats:bold> The group with the greater leiomyoma reduction after treatment with goserelin (group Ib) showed a significantly lower percentage of ER+ when compared with group Ia and the control group. Group Ib had a significantly higher percentage of PR+ in relation to the control group, but not to group Ia. The number of blood vessels, AgNOR dots, and cells, and the amount of collagen were not different between the three groups studied. Leiomyomata reduction correlated negatively with the percentage ER+ cells, but positively with the PR+ cells, amount of collagen and number of blood vessels. No correlation was found between the number of AgNOR dots and cellularity.<\/jats:p><jats:p><jats:bold>Conclusion.<\/jats:bold> Our data strengthen the hypothesis that the uterine leiomyoma response to steroid hormones results from the presence of specific hormone receptors, and progesterone receptors may also play a role in the development of leiomyoma.<\/jats:p>","DOI":"10.1034\/j.1600-0412.2003.00049.x","type":"journal-article","created":{"date-parts":[[2004,12,19]],"date-time":"2004-12-19T01:09:16Z","timestamp":1103418556000},"page":"330-334","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure"],"prefix":"10.1111","volume":"82","author":[{"given":"Nilo","family":"Bozzini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Consuelo J.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domingos A.","family":"Petti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruy G.","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio P.","family":"Gon\u00c7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Aristodemo","family":"Pinotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,4,25]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"36","article-title":"Growth potential of human uterine s: Some In vitro observations and their implications","volume":"66","author":"Cramer SF","year":"1985","journal-title":"Obstet Gynecol"},{"key":"e_1_2_6_3_2","first-page":"19","article-title":"Intratumoral blood flow in uterine myoma correlated with a lower tumor size and volume, but not correlated with cell proliferation or angiogenesis","volume":"87","author":"Huang SC","year":"1996","journal-title":"Obstet Gynecol"},{"key":"e_1_2_6_4_2","first-page":"20","article-title":"Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues","volume":"55","author":"Wilson EA","year":"1980","journal-title":"Obstet Gynecol"},{"key":"e_1_2_6_5_2","first-page":"941","article-title":"Action du decapeptyl (D\u2010Trp 6 GnRH) sur les r\u00e9cepteurs oestrog\u00e9nique, les r\u00e9cepteurs de la progesterone et sur la concentracion tissulaire d'oestrog\u00e8nes (non\u2010conjugu\u00e9s et sous forme sulfate) chez des patientes atteintes de fibrome ut\u00e9rin","volume":"38","author":"Pasqualine JR","year":"1990","journal-title":"Pathol Biol"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016349309021115"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0301-2115(95)02219-W"},{"key":"e_1_2_6_8_2","first-page":"1131","volume-title":"Blaunstein Pathology of the Female Genital Tract","author":"Zumi N","year":"1994"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711580303"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000213796"},{"key":"e_1_2_6_11_2","volume-title":"SPSS\u00ae for WindowsTM base system.","author":"Norus MJ","year":"1993"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(98)90116-2"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016349409015773"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)90440-I"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)61022-1"},{"key":"e_1_2_6_16_2","first-page":"901","article-title":"The concentrations of collagen\u2010associated amino acids are higher in GnRH agonist\u2010treated uterine myomas","volume":"82","author":"Rein MS","year":"1993","journal-title":"Obstet Gynecol"},{"key":"e_1_2_6_17_2","first-page":"442","article-title":"Morphometric and electron\u2010microscopic analyses of the effects of GnRH agonists on uterine leiomyomas","volume":"122","author":"Kalir T","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000052953"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-199507000-00007"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0015-0282(16)56177-9","article-title":"Leuprolide acetate depot decreases the number of nucleolar organizer regions in uterine leiomyomata","volume":"60","author":"Barbieri RL","year":"1993","journal-title":"Fertil Steril"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2002.31298"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0015-0282(16)53937-5","article-title":"Histophatological changes in leiomyomas treated with leuprolide acetate","volume":"54","author":"Upadhyaya NB","year":"1990","journal-title":"Fertil Steril"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0412.2003.00049.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0412.2003.00049.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0412.2003.00049.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:47:05Z","timestamp":1697244425000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0412.2003.00049.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["10.1034\/j.1600-0412.2003.00049.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0412.2003.00049.x","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4]]},"assertion":[{"value":"2003-04-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}